Medicamen Organics Limited (NSE:MEDIORG)
34.20
-1.80 (-5.00%)
At close: Sep 8, 2025
Medicamen Organics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Cash & Equivalents | 41.3 | 5.53 | 5.28 | 4.37 | 9.01 | Upgrade |
Cash & Short-Term Investments | 41.3 | 5.53 | 5.28 | 4.37 | 9.01 | Upgrade |
Cash Growth | 646.89% | 4.70% | 20.76% | -51.48% | 11.86% | Upgrade |
Receivables | 258.52 | 167 | 107.68 | 62.45 | 75.29 | Upgrade |
Inventory | 74.89 | 61.43 | 61.39 | 47.22 | 26.61 | Upgrade |
Prepaid Expenses | 0.54 | 0.44 | 1.09 | 1.17 | 1 | Upgrade |
Other Current Assets | 79.06 | 38.73 | 33.22 | 39.06 | 36.73 | Upgrade |
Total Current Assets | 454.32 | 273.12 | 208.66 | 154.28 | 148.64 | Upgrade |
Property, Plant & Equipment | 123.31 | 104.86 | 108.57 | 112.77 | 105.06 | Upgrade |
Long-Term Investments | 0.25 | 0.25 | 0.21 | 0.03 | - | Upgrade |
Goodwill | 0.01 | - | - | - | - | Upgrade |
Other Intangible Assets | 0.14 | 0.1 | 0.12 | 0.14 | 0.13 | Upgrade |
Other Long-Term Assets | 14.05 | 6.08 | 8.3 | 8.16 | 1.41 | Upgrade |
Total Assets | 592.07 | 384.4 | 325.86 | 275.38 | 255.24 | Upgrade |
Accounts Payable | 117.03 | 70.8 | 89.99 | 73.09 | 75.61 | Upgrade |
Accrued Expenses | 9.17 | 8.05 | 6.23 | 4.68 | 1.33 | Upgrade |
Short-Term Debt | 120.57 | 123.3 | 111.54 | 91.84 | 84.18 | Upgrade |
Current Portion of Long-Term Debt | 1.39 | 1.65 | 3.15 | 4.21 | 0.17 | Upgrade |
Current Income Taxes Payable | 13.58 | 9.04 | 3.69 | 0.77 | 1 | Upgrade |
Other Current Liabilities | 9.82 | 3.36 | 4.4 | 0.83 | 3.09 | Upgrade |
Total Current Liabilities | 271.56 | 216.19 | 218.99 | 175.42 | 165.39 | Upgrade |
Long-Term Debt | 1.58 | 1.61 | 3.26 | 6.41 | 11.54 | Upgrade |
Long-Term Deferred Tax Liabilities | 11.6 | 11.85 | 11.65 | 11.14 | 2.73 | Upgrade |
Other Long-Term Liabilities | 0.45 | 0.4 | 0.44 | 0.41 | 0.38 | Upgrade |
Total Liabilities | 287.27 | 231.81 | 236.06 | 195.27 | 181.63 | Upgrade |
Common Stock | 117 | 86 | 60 | 60 | 60 | Upgrade |
Additional Paid-In Capital | 95.54 | 21.14 | 9.14 | 9.14 | 9.14 | Upgrade |
Retained Earnings | 81.25 | 45.45 | 20.66 | 10.96 | 4.46 | Upgrade |
Comprehensive Income & Other | 7.5 | - | - | - | - | Upgrade |
Total Common Equity | 301.29 | 152.59 | 89.8 | 80.11 | 73.6 | Upgrade |
Minority Interest | 3.51 | - | - | - | - | Upgrade |
Shareholders' Equity | 304.81 | 152.59 | 89.8 | 80.11 | 73.6 | Upgrade |
Total Liabilities & Equity | 592.07 | 384.4 | 325.86 | 275.38 | 255.24 | Upgrade |
Total Debt | 123.53 | 126.57 | 117.95 | 102.46 | 95.9 | Upgrade |
Net Cash (Debt) | -82.23 | -121.04 | -112.67 | -98.08 | -86.88 | Upgrade |
Net Cash Per Share | -7.44 | -16.00 | -18.78 | -16.35 | -14.48 | Upgrade |
Filing Date Shares Outstanding | 11.7 | 8.6 | 6 | 6 | 6 | Upgrade |
Total Common Shares Outstanding | 11.7 | 8.6 | 6 | 6 | 6 | Upgrade |
Working Capital | 182.76 | 56.93 | -10.33 | -21.14 | -16.75 | Upgrade |
Book Value Per Share | 25.75 | 17.74 | 14.97 | 13.35 | 12.27 | Upgrade |
Tangible Book Value | 301.15 | 152.49 | 89.68 | 79.97 | 73.48 | Upgrade |
Tangible Book Value Per Share | 25.74 | 17.73 | 14.95 | 13.33 | 12.25 | Upgrade |
Land | 6.19 | 6.19 | 5.37 | 5.37 | 5.37 | Upgrade |
Buildings | 54.56 | 54.56 | 47.96 | 47.84 | 47.84 | Upgrade |
Machinery | 122.06 | 118.35 | 113.31 | 110.55 | 104.35 | Upgrade |
Construction In Progress | 22.16 | 1.46 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.